BRIEF published on 04/28/2025 at 09:13, 7 months 6 days ago MVISE AG Reports Robust First Quarter in 2025 EBITDA Financial Performance Growth Forecast MVISE AG Q1 2025 Results
PRESS RELEASE published on 04/28/2025 at 09:08, 7 months 6 days ago mVISE AG: strong first quarter of 2025 mVISE AG reports a strong first quarter of 2025 with EUR 0.31 million EBITDA and a 17.2% margin, aiming for +15% EBITDA growth for the year. CEO Ralf Thomas highlights successful market entry despite macroeconomic conditions EBITDA Growth Forecast First Quarter 2025 MVISE AG Ralf Thomas
BRIEF published on 03/27/2025 at 10:07, 8 months 8 days ago NuWays Issues 'Buy' Recommendation for mVISE AG Profitability Buy Recommendation Price Target NuWays MVISE AG
PRESS RELEASE published on 03/27/2025 at 10:02, 8 months 8 days ago Research update from NuWays available - 'Buy' recommendation and price target of EUR 1.30 mVISE AG receives 'Buy' recommendation with EUR 1.30 price target in research update from NuWays AG. Strong increase in profitability and successful strategic realignment highlighted Profitability NuWays AG Research Update Strategic Realignment MVISE AG
BRIEF published on 03/26/2025 at 09:07, 8 months 9 days ago MVISE AG Shows Profitability Amid Sales Decline Buy Recommendation EBITDA Growth FY24 Results MVISE AG Restructuring Impact
PRESS RELEASE published on 03/26/2025 at 09:02, 8 months 9 days ago Original-Research: mVISE AG (von NuWays AG): BUY mVISE AG releases FY24 figures showing increased profitability with sales decline but EBITDA improvement. New guidance targets 15% yoy EBITDA increase for FY25 Profitability Sales Decline Guidance MVISE AG FY24 Figures
BRIEF published on 02/04/2025 at 07:47, 10 months ago MVISE AG Benefit from Significant Debt Waiver Financing Financial Support Extraordinary Income MVISE AG Debt Waiver
PRESS RELEASE published on 02/04/2025 at 07:42, 10 months ago EQS-Adhoc: mVISE AG: Debt waiver in favour of mVISE AG mVISE AG receives debt waiver of almost EUR 300,000 from consortium FHMT, strengthening financial position. Debt waiver recognized as extraordinary income in 2025 Financial Position MVISE AG Debt Waiver EUR 300,000 FHMT
BRIEF published on 01/30/2025 at 09:06, 10 months 5 days ago MVISE AG Sees Positive Transformation with Investor Support Refinancing Investor Confidence EBITDA Growth MVISE AG Buy & Build
PRESS RELEASE published on 01/30/2025 at 09:01, 10 months 5 days ago Original-Research: mVISE AG (von NuWays AG): Buy mVISE AG, under Finanzhaus Main Tauber's lead, clears bank liabilities worth €2.3m. Positive outlook post refinancing - aiming for growth in DACH region Refinancing DACH Region Investment Case MVISE AG Bank Liabilities
Published on 12/05/2025 at 02:35, 3 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 56 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 1 minute ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 11 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 16 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 42 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 25 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
